Rezurock
- Product NDC
- 79802-200
- 11-digit product format
- 798020200
- Labeler code
- 79802
- Product ID
- 79802-200_65249371-3fc5-4a85-a999-9ed367b8dd73
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- belumosudil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Kadmon Pharmaceuticals, LLC
- Application
- NDA214783
- Marketing category
- NDA
- Marketing start
- 2021-07-16
- Substance
- BELUMOSUDIL
- Active strength
- 200 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rezurock
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BELUMOSUDIL | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 834YJF89WO |
| Rxcui | 2564031, 2564037 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 79802-200-30 | Rezurock | 30 in 1 BOTTLE | TABLET | 30 | | 11 |
| 79802-200-30 | Rezurock | 1 in 1 CARTON | TABLET | 1 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 79802-200 | REZUROCK (BELUMOSUDIL) TABLET [KADMON PHARMACEUTICALS, LLC] | 9 | Current NDC, Legacy NDC, 2 package rows | 20250430_102e4ef4-7f84-4e34-8df1-479c24d1575d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 79802-200-30 | 79802020030 | 1 BOTTLE in 1 CARTON (79802-200-30) / 30 TABLET in 1 BOTTLE | 1 bottle | 2021-07-16 | 0000-00-00 | No | No | Current |